Cargando…

Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation

PURPOSE: Retrospective evaluation of toxicity and results after radiochemotherapy for glioblastoma. METHODS: 46 patients with histopathologically proven glioblastoma received simultaneous radiochemotherapy (RCT). The mean age at the beginning of therapy was 59 years, the mean Karnofsky performance i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niewald, Marcus, Berdel, Christian, Fleckenstein, Jochen, Licht, Norbert, Ketter, Ralf, Rübe, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213071/ https://www.ncbi.nlm.nih.gov/pubmed/22017800 http://dx.doi.org/10.1186/1748-717X-6-141

Ejemplares similares

Intraoperative radiotherapy (IORT) combined with external beam radiotherapy (EBRT) for soft-tissue sarcomas – a retrospective evaluation of the Homburg experience in the years 1995–2007
por: Niewald, Marcus, et al.
Publicado: (2009)

Dental status, dental rehabilitation procedures, demographic and oncological data as potential risk factors for infected osteoradionecrosis of the lower jaw after radiotherapy for oral neoplasms: a retrospective evaluation
por: Niewald, Marcus, et al.
Publicado: (2013)

Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
por: Lewitzki, Victor, et al.
Publicado: (2019)

Long-term results of radiotherapy for periarthritis of the shoulder: a retrospective evaluation
por: Niewald, Marcus, et al.
Publicado: (2007)

Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis
por: Klement, Rainer J., et al.
Publicado: (2021)

Dental status, dental treatment procedures and radiotherapy as risk factors for infected osteoradionecrosis (IORN) in patients with oral cancer – a comparison of two 10 years’ observation periods
por: Niewald, Marcus, et al.
Publicado: (2014)

Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
por: Combs, Stephanie E, et al.
Publicado: (2010)

ArthroRad trial: multicentric prospective and randomized single-blinded trial on the effect of low-dose radiotherapy for painful osteoarthritis depending on the dose—results after 3 months’ follow-up
por: Niewald, Marcus, et al.
Publicado: (2021)

mARC Treatment of Hypopharynx Carcinoma with Flat and Flattening-Filter-Free Beam Energies – A Planning Study
por: Bell, Katharina, et al.
Publicado: (2016)

Comparative Planning of Flattening-Filter-Free and Flat Beam IMRT for Hypopharynx Cancer as a Function of Beam and Segment Number
por: Dzierma, Yvonne, et al.
Publicado: (2014)

Bilateral posterior RION after concomitant radiochemotherapy with temozolomide in a patient with glioblastoma multiforme: a case report
por: Schreiber, Stefanie, et al.
Publicado: (2010)

Feasibility and clinical usefulness of modelling glioblastoma migration in adjuvant radiotherapy
por: Knobe, Sven, et al.
Publicado: (2021)

Influence of daily imaging on plan quality and normal tissue toxicity for prostate cancer radiotherapy
por: Bell, Katharina, et al.
Publicado: (2017)

Assessment of DNA damage by 53PB1 and pKu70 detection in peripheral blood lymphocytes by immunofluorescence and high-resolution transmission electron microscopy
por: Lorat, Yvonne, et al.
Publicado: (2020)

Toxicity and Outcome of Radiotherapy with Concomitant and Adjuvant Temozolomide in Elderly Patients with Glioblastoma: A Retrospective Study
por: SAITO, Kuniaki, et al.
Publicado: (2014)

Image guidance and positioning accuracy in clinical practice: influence of positioning errors and imaging dose on the real dose distribution for head and neck cancer treatment
por: Bell, Katharina, et al.
Publicado: (2018)

Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol)
por: Thivat, Emilie, et al.
Publicado: (2023)

Randomized multicenter follow-up trial on the effect of radiotherapy on painful heel spur (plantar fasciitis) comparing two fractionation schedules with uniform total dose: first results after three months’ follow-up
por: Niewald, Marcus, et al.
Publicado: (2015)

Radiochemotherapy
Publicado: (1998)

Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis
por: Fleckenstein, Jochen, et al.
Publicado: (2015)

Cytokine Plasma Levels: Reliable Predictors for Radiation Pneumonitis?
por: Rübe, Claudia E., et al.
Publicado: (2008)

Evaluation of Temozolomide and Fingolimod Treatments in Glioblastoma Preclinical Models
por: Davy, Mélodie, et al.
Publicado: (2023)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Monte-Carlo simulation of the Siemens Artiste linear accelerator flat 6 MV and flattening-filter-free 7 MV beam line
por: Sadrollahi, Alemeh, et al.
Publicado: (2019)

Senescence Is the Main Trait Induced by Temozolomide in Glioblastoma Cells
por: Beltzig, Lea, et al.
Publicado: (2022)

First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience
por: Bock, Hans Christoph, et al.
Publicado: (2010)

Temozolomide chronotherapy in patients with glioblastoma: a retrospective single-institute study
por: Damato, Anna R, et al.
Publicado: (2021)

Visualisation of Respiratory Tumour Motion and Co-Moving Isodose Lines in the Context of Respiratory Gating, IMRT and Flattening-Filter-Free Beams
por: Dzierma, Yvonne, et al.
Publicado: (2013)

Correction: Visualisation of Respiratory Tumour Motion and Co-Moving Isodose Lines in the Context of Respiratory Gating, IMRT and Flattening-Filter-Free Beams
por: Dzierma, Yvonne, et al.
Publicado: (2013)

Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume
por: Piroth, Marc D., et al.
Publicado: (2016)

Accelerated hyperfractionation plus temozolomide in glioblastoma
por: Kaul, David, et al.
Publicado: (2016)

Strategies of temozolomide in future glioblastoma treatment
por: Lee, Chooi Yeng
Publicado: (2017)

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
por: Saha, Dipongkor, et al.
Publicado: (2020)

A Retrospective Study on Radiotherapy and Radiochemotherapy in Esophageal Cancer
por: Kim, Chang-Min, et al.
Publicado: (1988)

Obstacles to Glioblastoma Treatment Two Decades after Temozolomide
por: Cruz, João Victor Roza, et al.
Publicado: (2022)

Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer
por: Fleckenstein, Jochen, et al.
Publicado: (2016)

Salvage laryngectomy after primary radio- and radiochemotherapy: A retrospective study
por: Sievert, Matti, et al.
Publicado: (2021)

Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea
por: Kim, Byung Sup, et al.
Publicado: (2017)

mARC vs. IMRT radiotherapy of the prostate with flat and flattening-filter-free beam energies
por: Dzierma, Yvonne, et al.
Publicado: (2014)

Temozolomide Combined With Capecitabine In The Treatment Of Mixed Neuroendocrine Carcinoma Of The Lung With Poor Tolerance After Repeated Radiochemotherapy: A Case Report And Literature Review
por: Zhang, Bin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cq3d5n4sj032o7itlnn70rm4nd